NasdaqGS - Delayed Quote • USD
Regeneron Pharmaceuticals, Inc. (REGN)
At close: April 24 at 4:00 PM EDT
Pre-Market: 8:43 AM EDT
Contract Name | Last Trade Date (EDT) | Expire Date | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
---|---|---|---|---|---|---|---|---|---|---|
REGN240503C00660000 | 4/12/2024 5:11 PM | 2024-05-03 | 243.00 | 0.00 | 0.00 | 0.00 | 0.00% | 1 | 1 | 0.00% |
REGN240621C00660000 | 10/27/2023 7:24 PM | 2024-06-21 | 157.60 | 168.60 | 173.50 | 0.00 | 0.00% | 3 | 1 | 0.00% |
REGN250117C00660000 | 2/1/2024 5:59 PM | 2025-01-17 | 340.00 | 358.00 | 366.00 | 0.00 | 0.00% | 1 | 7 | 83.37% |
REGN250620C00660000 | 3/1/2024 3:11 PM | 2025-06-20 | 367.87 | 354.00 | 364.00 | 0.00 | 0.00% | 5 | 5 | 65.37% |
REGN251219C00660000 | 7/13/2023 1:36 PM | 2025-12-19 | 199.64 | 262.20 | 269.00 | 0.00 | 0.00% | - | 10 | 25.53% |
Contract Name | Last Trade Date (EDT) | Expire Date | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
---|---|---|---|---|---|---|---|---|---|---|
REGN240517P00660000 | 4/4/2024 7:55 PM | 2024-05-17 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00% | 1 | 81 | 25.00% |
REGN240621P00660000 | 2/29/2024 8:02 PM | 2024-06-21 | 3.70 | 0.05 | 4.80 | 0.00 | 0.00% | 4 | 41 | 53.14% |
REGN240816P00660000 | 4/10/2024 7:43 PM | 2024-08-16 | 3.50 | 0.00 | 0.00 | 0.00 | 0.00% | 6 | 3 | 12.50% |
REGN250117P00660000 | 4/17/2024 4:14 PM | 2025-01-17 | 11.82 | 0.00 | 0.00 | 0.00 | 0.00% | 3 | 153 | 6.25% |
REGN251219P00660000 | 1/31/2024 3:27 PM | 2025-12-19 | 22.30 | 0.00 | 0.00 | 0.00 | 0.00% | 2 | 12 | 6.25% |
REGN260116P00660000 | 1/31/2024 5:25 PM | 2026-01-16 | 23.40 | 16.60 | 25.00 | 0.00 | 0.00% | - | 4 | 26.00% |
Related Tickers
VRTX Vertex Pharmaceuticals Incorporated
400.76
-1.02%
BNTX BioNTech SE
88.09
-0.45%
ALNY Alnylam Pharmaceuticals, Inc.
143.80
-1.55%
MDGL Madrigal Pharmaceuticals, Inc.
204.65
-6.29%
BMRN BioMarin Pharmaceutical Inc.
91.20
-0.93%
MRNA Moderna, Inc.
108.85
+0.89%
CRSP CRISPR Therapeutics AG
55.65
-1.35%
INCY Incyte Corporation
51.74
+0.17%
NTLA Intellia Therapeutics, Inc.
21.17
-1.67%
NVO Novo Nordisk A/S
126.16
-1.93%